Revolution Medicines, Total Stockholder Equity Over Time
| RVMDW Stock | 0.35 0.01 2.94% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Revolution Medicines, Performance and Revolution Medicines, Correlation. Revolution |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revolution Medicines,. If investors know Revolution will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revolution Medicines, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.005 | Return On Assets (0.29) | Return On Equity (0.47) |
The market value of Revolution Medicines, is measured differently than its book value, which is the value of Revolution that is recorded on the company's balance sheet. Investors also form their own opinion of Revolution Medicines,'s value that differs from its market value or its book value, called intrinsic value, which is Revolution Medicines,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revolution Medicines,'s market value can be influenced by many factors that don't directly affect Revolution Medicines,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revolution Medicines,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Revolution Medicines, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revolution Medicines,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Stockholder Equity Analysis
Compare Revolution Medicines, and related stocks such as GoHealth, Old Republic Interna, and Palomar Holdings Total Stockholder Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GOCO | (186.7 M) | (186.7 M) | (186.7 M) | (186.7 M) | (186.7 M) | (186.7 M) | (186.7 M) | (186.7 M) | (186.7 M) | 860.1 M | 378.8 M | 353.1 M | 318.1 M | 231 M | 358.3 M |
| ORI | 381.2 M | 3.8 B | 3.6 B | 3.8 B | 3.9 B | 3.9 B | 4.5 B | 4.7 B | 5.1 B | 6 B | 6.2 B | 6.9 B | 6.2 B | 6.4 B | 3.5 B |
| PLMR | 73.1 M | 73.1 M | 73.1 M | 73.1 M | 73.1 M | 73.1 M | 73.1 M | 78.4 M | 91.2 M | 218.6 M | 363.7 M | 394.2 M | 384.8 M | 471.3 M | 285.3 M |
| RBC | (38.1 M) | 385.8 M | 462.2 M | 538.5 M | 549.4 M | 620.9 M | 717 M | 834.6 M | 968.6 M | 1.1 B | 1.2 B | 2.4 B | 2.5 B | 2.8 B | 2.9 B |
| TTC | 63.1 M | 312.4 M | 358.7 M | 408.7 M | 462.2 M | 550 M | 617.1 M | 668.9 M | 859.6 M | 1.1 B | 1.2 B | 1.4 B | 1.5 B | 1.7 B | 1.8 B |
| AEG | 1.5 B | 25.7 B | 29.7 B | 25 B | 28.1 B | 26.2 B | 24.7 B | 24.4 B | 22.5 B | 24.4 B | 24.6 B | 26.2 B | 14 B | 9.4 B | 15.5 B |
Revolution Medicines, and related stocks such as GoHealth, Old Republic Interna, and Palomar Holdings Total Stockholder Equity description
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.My Equities
My Current Equities and Potential Positions
| Revolution Medicines, Warrant | RVMDW |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 0.35
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.